ReviewFrontiers in psychiatry2025
Klinefelter syndrome and ADHD: a short systematic review.
Review in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Growing up with Klinefelter syndrome: challenges of care in children and adolescents and patients advocacy.Endocrine · 2026Review
- Development and validation of the Klinefelter-Associated Neurodevelopmental Difficulties (KAND) Checklist: a three-phase mixed-methods study.Journal of neurodevelopmental disorders · 2026Article
- The gender-sensitive spectrum of neurodevelopmental disorders: a case report on aFrontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Klinefelter Syndrome (KS) is the most common sex chromosome anomaly in the world, and it is characterized by the presence of an extra X chromosome (47, XXY). It affects approximately 1 in 500 to 1 in 1000 male births and it has been associated with various neurodevelopmental conditions, including Attention Deficit Hyperactivity Disorder (ADHD). This systematic review aims to collect and analyze existing literature on the comorbidity of KS and ADHD. A comprehensive search was conducted following PRISMA guidelines in Medline and Web of Science, covering studies from 1959 to 2024. After screening and applying inclusion/exclusion criteria, 15 studies were selected for analysis. The findings suggest a significant association between KS and ADHD, particularly concerning the inattentive subtype. Several studies reported an increased prevalence of ADHD in individuals with KS compared to the general population, with estimates ranging from 25% to 63%. Some research also indicated a higher risk for comorbid conditions such as Autism Spectrum Disorder (ASD) and mood disorders. Neuroimaging studies highlighted structural and functional differences in KS patients compared with controls, particularly in brain regions involved in executive function, working memory, and attention regulation. Despite these findings, no study provided conclusive evidence regarding a causal relationship between KS and ADHD. Additionally, pharmacological treatment for ADHD appears to be effective and well-tolerated in KS patients, with minimal side effects. Overall, this review underscores the complex and heterogeneous nature of KS-ADHD comorbidity; however, variability in study populations and methodologies limits the ability to draw definitive conclusions. Further research is necessary to clarify the potential mechanisms linking KS and ADHD and to develop tailored clinical approaches for individuals affected by both conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.